Christian Behrenbruch
Follow
Get notifications in MyBN when activity occurs.
Christian Behrenbruch
Chief Executive, Managing Director / Telix Pharmaceuticals
Dr Christian Behrenbruch has over 20 years of healthcare entrepreneurship and executive leadership experience.
Dr Behrenbruch was the chief executive and executive director of capacity at Mirada Solutions, CTI Molecular Imaging (now Siemens Healthcare), Fibron Technologies and ImaginAb. He was also a director of Momentum Biosciences LLC, Siemens Molecular Imaging, Radius Health (now Adaptix), and former chair of Cell Therapies (a partnership with the Peter MacCallum Cancer Centre).
Dr Behrenbruch was the chief executive and executive director of capacity at Mirada Solutions, CTI Molecular Imaging (now Siemens Healthcare), Fibron Technologies and ImaginAb. He was also a director of Momentum Biosciences LLC, Siemens Molecular Imaging, Radius Health (now Adaptix), and former chair of Cell Therapies (a partnership with the Peter MacCallum Cancer Centre).
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 105th | Telix Pharmaceuticals | 137% | 66% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Telix Pharmaceuticals | $499.1m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
 | NEW ROLE: Chief Executive, Managing Director, Telix Pharmaceuticals | 03 Nov 2020 |
